期刊文献+

HIV-1 CAP2NC蛋白的表达及体外自组装

Expression and self-assembly of HIV-1 CAP2NC protein
原文传递
导出
摘要 构建并表达HIV-1 CAP2NC蛋白,探索其体外自组装条件。通过PCR技术扩增HIV-1(NL4-3毒株)CAP2NC基因片段,并将其连接到原核表达载体pTO-T7,获得重组质粒pTO-T7-CAP2NC,然后转化至大肠杆菌BL21(DE3)菌株,经疏水层析纯化后获得重组蛋白CAP2NC。SDS-PAGE结果表明,重组蛋白CAP2NC可在大肠杆菌可溶高效表达,经纯化后纯度约为95%。ELISA检测表明重组蛋白CAP2NC可被HIV-1衣壳蛋白特异性单克隆抗体识别,具有较好反应活性。重组蛋白透析后在非原性SDS-PAGE中呈现为多种聚体形式。分子筛排阻层析分析CAP2NC蛋白透析后可进行组装,负染电镜进一步观察显示CAP2NC蛋白在RNA存在条件下,可形成空心管状颗粒,其形态结构与HIV-1病毒衣壳体外自组装形成的类似。上述结果表明HIV-1 CAP2NC蛋白具有体外自组装的性质,为进一步在体外研究非成熟病毒样颗粒结构奠定基础。 We constructed the CAP2NC prokaryotic expression vector of HIV-1NL4-3 strain and obtained relatively pure CAP2NC protein by optimizing its purification conditions to explore its in vitro self-assembly conditions. Primers were designed according to the CAP2NC DNA sequence of HIV-1 NL4-3 strain. The target gene was amplified by PCR and cloned into prokaryotic expression vector pTO-T7. Then the recombinant strain was transformed into Escherichia coli BL21(DE3).IPTG induced protein expression, then the protein was purified by hydrophobic chromatography. SDS-PAGE and Western blotting were performed to analyze the target protein, and the biological activity of the antigen was identified through ELISA. The self-assembly of CAP2NC protein was analyzed by transmission electron microscopy and gel filtration chromatography. The protein had good reaction with the specific antibodies of p24 and formed different structures in various conditions. When 10% yeast RNA was added to the protein complex, the recombinant protein only formed into a tubular structure, which was similar to the self-assembled structure of the HIV-1 virus capsid. The results showed that the HIV-1 CAP2NC protein had in vitro self-assembly activity, and the RNA affected the structure of CAP2NC protein assembly. The protein can be used as a simple and effective molecular model to study its structure, and then it can provide a reference for the study of HIV immature virus particles.
作者 白诗梦 张芝晴 乔佳明 沈鸿霖 黄芳 高双全 李少勇 李少伟 夏宁邵 顾颖 Shimeng Bai;Zhiqing Zhang;Jiaming Qiao;Honglin Shen;Fang Huang;Shuangquan Gao;Shaoyong Li;Shaowei Li;Ningshao Xia;Ying Gu(National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, Fujian, China)
出处 《生物工程学报》 CAS CSCD 北大核心 2018年第4期586-593,共8页 Chinese Journal of Biotechnology
基金 国家自然科学基金(Nos.81671645 81371818)资助~~
关键词 HIV-1 CAP2NC蛋白 自组装 HIV- 1, CAP2NC protein, self-assembly property
  • 相关文献

参考文献2

二级参考文献31

  • 1萨姆布鲁克J 金冬雁等(译).分子克隆操作指南(第2版)[M].北京:科学出版社,1992..
  • 2朱玉贤 李毅.现代分子生物学[M].北京:高等教育出版社,1998.195.
  • 3[1]Agrawal L,Lu X,Jin Q,et al.Anti-HIV therapy:current and future directions[J].Curr Pharm Des,2006,12(16):2031-2055.
  • 4[2]Perales C,Carrasco L,González ME.Regulation of HIV-1 env mRNA translation by Rev protein[J].Biochim Biophys Acta,2005,1743(1/2):169-175.
  • 5[3]Kudo N,Wolff B,Sekimoto T,et al.Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1[J].Exp Cell Res,1998,242(2):540-547.
  • 6[4]Li K,Davis TM,Bailly C,et al.A heterocyclic inhibitor of the Rev-RRE complex binds to RRE as a dimer[J].Biochemistry,2001,40(5):1150-1158.
  • 7[5]Daelemans D,Afonina E,Nilsson J,et al.A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export[J].Proc Natl Acad Sci USA,2002,99(22):14440-14445.
  • 8[6]Goldstein G.HIV-1 Tat protein as a potential AIDS vaccine[J].Nat Med,1996,2(9):960-964.
  • 9[7]Montembault M,Vo-Thanh G,Deyine A,et al.A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor[J].Bioorg Med Chem Lett,2004,14(6):1543-1546.
  • 10[8]Murchie AI,Davis B,Isel C,et al.Structure-based drug design targeting an inactive RNA conformation:exploiting the flexibility of HIV-1 TAR RNA[J].J Mol Biol,2004,336(3):625-638.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部